Article
Amelioration of non-alcoholic fatty liver disease by targeting G protein-coupled receptor 110: A preclinical study
2022-12-12
Abstract excerpt
<h4>Background</h4> Recent research has shown that the G protein-coupled receptor 110 (GPR110) is an oncogene. The evidence mainly based on high expression of GPR110 in numerous cancer types; and knockdown GPR110 can reduced the cell migration, invasion, and proliferation. GPR110 is, however, mostly expressed in the liver of healthy individuals. The function of GPR110 in liver has not been revealed. Interestingly...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6e2011d0-e940-505d-acca-6e0bc5b8b69f
- DOI
- 10.1101/2022.12.07.22283206
